Cetrorelix Acetate for Injection Recall: Meitheal Kit
Announced 2026-02-18 · FDA
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate for Injection kits due to a defective delivery system with missing or duplicated needles. About 16,477 kits distributed nationwide in the United States are affected by Lot Q4E0112A, expiring 30 Apr 2027. The recall is being overseen by the FDA.
| Brand | Meitheal Pharmaceuticals, Inc |
|---|---|
| Product | Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. |
| Reason | Defective Delivery System: Missing or duplicated needles within the injection kit |
| Severity | moderate |
| Units affected | 16477 |
| Distribution | U.S. Nationwide |
| Agency | FDA |
| Recall / campaign no. | Lot Q4E0112A, Exp.: 30 Apr 2027 |
WHAT YOU SHOULD DO
- If you have a kit from Lot Q4E0112A, stop using it immediately.
- Contact your healthcare provider or Meitheal Pharmaceuticals for disposal or replacement instructions.
- Check the lot number on your kit and follow FDA guidance for recalls.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.